Details of the Drug

General Information of Drug (ID: DME8A5R)

Drug Name

OPS-2071

Indication

Disease Entry	ICD 11	Status	REF
Crohn disease	DD70	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small interfering RNA

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03850509) Efficacy and Safety of Oral OPS-2071 in Subjects With Crohn's Disease Showing Symptoms of Active Inflammation. U.S. National Institutes of Health.